Company News

FDA Approves Sculptra

Injectable for correction of nasolabial folds and other facial wrinkles

Sanofi-Aventis U.S. announced that the U.S. Food and Drug Administration (FDA) approved Sculptra Aesthetic (injectable poly-L-lactic acid).

According to the company, it was designed for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles.




Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters